Equities
IndustrialsGeneral Industrials
  • Price (USD)--
  • Today's Change--
  • Shares traded25.00
  • 1 Year change--
  • Beta1.4303
Data delayed at least 15 minutes, as of Feb 05 2026 16:49 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Daetwyler Holding AG is a Switzerland-based industrial supplier of system-critical elastomer components for healthcare, mobility, connectivity, general industry and food & beverages industry. The Company operates through two divisions. The Healthcare Solutions division offers system-critical components for containers and delivery systems for injectable drugs and diagnostics in the pharmaceutical as well as medical markets. The Business Area Industrial Solutions manufactures customised system-critical components for applications in the Mobility, Connectors, General Industry and Food & Beverage markets. Manufacturing and distribution companies are mainly located in Germany, Italy, China and the USA.

  • Revenue in CHF (TTM)1.10bn
  • Net income in CHF30.40m
  • Incorporated1961
  • Employees7.70k
  • Location
    Daetwyler Holding AGGotthardstrasse 31ALTDORF 6460SwitzerlandCHE
  • Phone+41 418751100
  • Fax+41 418751205
  • Websitehttps://www.datwyler.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DAE:SWX since
announced
Transaction
value
Capsulinvest SAAnnounced19 Dec 202519 Dec 2025Announced7.52%--
Capsulin Pro SAAnnounced19 Dec 202519 Dec 2025Announced7.52%--
Brain Corp SAAnnounced19 Dec 202519 Dec 2025Announced7.52%--
Cheshire Anilox Technology LtdDeal completed25 Nov 202525 Nov 2025Deal completed5.34%--
Data delayed at least 15 minutes, as of Feb 06 2026 16:31 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.